Biotechnology Austria wants to be at the top of the podium in research and development In 2023, the share of R&D expenditure in Austria’s nominal gross domestic product (GDP) was 3.26%. This put Austria in third place in the EU after Belgium and Sweden. In 2024, the ratio will be 3.34% according to the estimate global by Statistics Austria, corresponding to a record sum of 16.64 billion euros. The Federal […] Written by Arno Fricke September 17, 2024September 17, 2024 Saving Bookmark this article Bookmarked
Scientists identify genes that make humans and Labradors more likely to become obese Researchers studying British Labrador retrievers have identified multiple genes associated with canine obesity and shown that these genes are also associated with obesity in humans. The dog gene found to be most strongly associated with obesity in Labradors is called DENND1B. Humans also carry the DENND1B gene, and the researchers found that this gene is […] Written by Admin March 7, 2025March 7, 2025 Saving Bookmark this article Bookmarked
Depemokimab Applications Accepted for Review by the US FDA for Asthma with Type 2 Inflammation and for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) London, UK — 03 March 2025 — GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application for the use of depemokimab in two indications. The proposed indications are… Written by Admin March 7, 2025March 7, 2025 Saving Bookmark this article Bookmarked
Scientists identify genes that make humans and Labradors more likely to become obese Researchers studying British Labrador retrievers have identified multiple genes associated with canine obesity and shown that these genes are also associated with obesity in humans. The dog gene found to be most strongly associated with obesity in Labradors is called DENND1B. Humans also carry the DENND1B gene, and the researchers found that this gene is […] Written by Admin March 7, 2025March 7, 2025 Saving Bookmark this article Bookmarked
Depemokimab Applications Accepted for Review by the US FDA for Asthma with Type 2 Inflammation and for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) London, UK — 03 March 2025 — GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application for the use of depemokimab in two indications. The proposed indications are… Written by Admin March 7, 2025March 7, 2025 Saving Bookmark this article Bookmarked
Ca 2+ binding to Esyt modulates membrane contact site density in Drosophila photoreceptors Membrane contact sites (MCS) between the plasma membrane (PM) and endoplasmic reticulum (ER) regulate Ca2+ influx. However, the mechanisms by which cells modulate ER–PM MCS density are not understood, and the role of Ca2+, if any, in regulating these is unknown. We report that in Drosophila photoreceptors, MCS density is regulated by the Ca2+ channels, […] Written by Admin March 6, 2025March 6, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked
